Pulmonary Disease Doctors in Quincy, IL Accepting Medicare

3 Pulmonary Disease doctors found. Showing 1 - 3

Umama Adil, MD Internal Medicine - Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1005 Broadway St, Quincy, IL 62301 Phone: 217-223-8400

Elie A Chbeir, MD Internal Medicine - Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1025 Maine St, Quincy, IL 62301 Phone: 217-222-6550

Venu Reddy, M.D. Internal Medicine - Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 927 Broadway St, Suite 204, Quincy, IL 62301 Phone: 217-224-6423    Fax: 217-223-9045

News Archive

Science and technology tours to be conducted in conjunction with the G20 Pittsburgh Summit

The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.

New technology by Neurodata Lab acquires accurate physiological data

New technology by Neurodata Lab is capable to acquire physiological data by simply pointing a webcam at one's face, with accuracy comparable to special wearable equipment.

Pyromaker can more accurately identify complex genetic mutations

DNA sequencing to detect genetic mutations can aid in the diagnosis and selection of treatment for cancer. Current methods of testing DNA samples, Sanger sequencing and pyrosequencing, occasionally produce complex results that can be difficult or impossible to interpret. Scientists at the Johns Hopkins University School of Medicine have developed a free software program, Pyromaker, that can more accurately identify such complex genetic mutations.

Lapatinib benefits found for HER2-positive early-stage patients

Women with early-stage, HER2-positive breast cancer who are unable to use trastuzumab may benefit from adjuvant lapatinib treatment, suggest phase III trial findings published in Lancet Oncology.

BioMarin completes BMN 195 Phase 1 clinical trial for Duchenne muscular dystrophy

BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.

Read more Medical News

› Verified 4 days ago